Quantitative research excellence
Our established team of quantitative directors and project managers are the driving force behind our Quantitative Centre of Excellence initiative, promoting best practice approaches for managing the implementation of new developments and emerging methodologies
Today, quantitative research faces a number of major challenges from both a sampling and budget perspective. We employ both tried and tested approaches as well as newer and more creative solutions to get below the surface and uncover the marketing truths.
Our experienced senior team supported by our talented researchers are equipped with the skills and creative flair to design and implement quantitative research solutions that take you further with your decision-making.
Our dedicated team of statisticians play a key role in supporting our healthcare market researchers. With their unique combination of therapeutic expertise and statistical knowledge, they consult research teams on ad-hoc study design, address methodological issues and challenges, and lead the application of advanced analytics throughout the business - delivering practical advice to both researchers and clients. In addition, they provide significant input into the development of new research approaches and methodologies to increase our portfolio of quantitative solutions. Our in-house team includes Advanced Analytics Directors Emily Beswick and Misti Paul, and Senior Analytics Executive Sarah Reynolds.
We offer complimentary one-hour tutorials which explore key quantitative research challenges that our clients are currently experiencing. Our tutorials are designed and delivered by pharma market research specialists with a wealth of experience in conducting quantitative studies
Misti Paul has over 16 years’ experience in statistical analysis and advanced analytics. Before joining Research Partnership, Misti founded Advanced Analytics providing advanced statistical consulting and solutions to global pharmaceutical, biotech and medical device companies. She specialised in the areas of segmentation, new product development, conjoint methodologies, merger and acquisition modelling, and other analytical techniques. She has been an invited speaker at the RSS (Royal Statistical Society) is a member on the journal committee for global organisation, Statisticians in the Pharmaceutical Society.
Director, Quantitative Research
Karen heads up our Quantitative Centre of Excellence team with Tom Nolte. Karen has over 15 years experience in healthcare research with specific focus on quantitative methods. Karen's research experience spans all methodologies; however she brings significant expertise in methods using advanced statistical techniques, global tracking and communications testing and message recall.
- Using demand assessment techniques to evaluate the market landscape and product opportunity
The challenge:Our client wanted to evaluate the potential of two treatments which would offer efficacy and side effects similar to those of biologics in atopic dermatitis. Therefore our client needed to understand more about the US and German market landscape in moderate-severe atopic dermatitis and how these advanced treatments might fit into the treatment algorithim when they are launched, as well as the potential drivers…read more »How a mindset-based customer segmentation was developed to drive engagement with physicians in oncology
The challenge:In preparation for the launch of a new oncology treatment in the EMEA region, our client wished to develop an attitudinal mindset-based customer segmentation. This would allow for clear identification of each segment in the field; effective deployment of the sales force at launch by prioritising segments that show the greatest opportunity; and segmented messages (and potentially sales aids) to directly address the needs…read more »How understanding patient willingness to pay in emerging markets helped identify the optimum price for a chronic disease brand
The challenge: Our client wanted to identify the optimum selling price for their chronic disease treatment in emerging markets, based on patient’s willingness to pay for the product out of pocket. The solution: After showing a product profile to patients within the target income group, we asked their likelihood to purchase the product and their estimated frequency of purchase over 12 months at a series…read more »